Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin

Exp Lung Res. 2014 Oct;40(8):404-414. doi: 10.3109/01902148.2014.938201. Epub 2014 Aug 25.

Abstract

Purpose: To investigate the effect of cisplatin on the growth and metastasis abilities of lung cancer stem cells (CSCs) via molecular imaging.

Materials and methods: The expression changes of lung CSCs cell marker in A549-Luc-C8 human non-small-cell lung cancer (NSCLC) cell line with or without cisplatin treatment were detected by flow cytometry. The tumorigenesis and metastasis abilities of A549-Luc-C8 cells were monitored both in vitro and in vivo, and the mechanism was assessed by gene sequencing.

Results: About 1%-2% of CSCs were detected in A549-Luc-C8 cells and decreased CSCs percentage was observed after cisplatin treatment. Attenuated tumorigenesis and metastasis abilities of A549-Luc-C8 cells were found in cisplatin treated group.

Conclusions: Decreased percentage of CSCs in A549-Luc-C8 cells can be induced by cisplatin treatment, which may partly be attributed to the attenuated expression of growth factors.

Keywords: cancer stem cells; cisplatin; growth factor; lung cancer; molecular imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Carcinogenesis / drug effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cell Line, Tumor
  • Cisplatin / pharmacology*
  • Cisplatin / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Mice, Nude
  • Neoplastic Stem Cells / drug effects*
  • Sequence Analysis, RNA

Substances

  • Antineoplastic Agents
  • Cisplatin